A variety of products have been developed to provide nicotine to a person trying to stop smoking. They can be effective when combined with other modalities. They lend themselves to unintended uses.
Products:
(1) transdermal patch (Nicoderm CQ, Glaxo Smith Kline)
(2) chewing gum (Nicorette, Glaxo Smith Kline)
(3) lozenge (Commit, Glaxo Smith Kline))
(4) inhaler (Nicotrol, Pfizer))
(5) nasal spray (Nicotrol NS, Pfizer)
|
Transdermal Patch |
Patient smokes < 10 cigarettes per day |
Patient smokes >= 10 cigarettes per day |
|
21 mg patch (step 1) |
NA |
weeks 1-6 |
|
14 mg patch (step 2) |
weeks 1-6 |
weeks 7-8 |
|
7 mg patch (step 3) |
weeks 7-8 |
weeks 9-10 |
|
Chewing Gum |
Patient smokes < 25 cigarettes per day |
Patient smokes >= 25 cigarettes per day |
|
Gum Dose |
2 mg |
4 mg |
|
Lozenge |
Patient first smokes <=30 minutes of waking |
Patient first smokes >30 minutes of waking |
|
Lozenge Dose |
4 mg |
2 mg |
|
Week in Program |
Number of Pieces Gum or Lozenge |
|
1 to 6 |
1 piece q2h |
|
7 to 9 |
1 piece q2-4h |
|
10 to 12 |
1 piece q4-8h |
|
Week in Program |
Inhaler Dose |
|
up to 12 weeks |
6-16 cartridges per day |
|
next 6-12 weeks |
gradual reduction (weaning phase) |
The nasal spray has a dose of 1 mg, given by taking 1 spray into each nostril (each spray 0,5 mg).
|
Nasal Spray |
Parameter |
|
duration of therapy |
12 weeks |
|
recommended dosing |
1-2 doses per hour |
|
maximum dose |
5 doses in 1 hours |
|
maximum dose per day |
40 doses (2.5 per hour for 16 hours) |
These products vary in cost, with the inhaler products reportedly more expensive.
Specialty: Toxicology, Emergency Medicine, Critical Care
ICD-10: ,
